Who owns the LIPONYX trademark?

The LIPONYX trademark is owned by Nikoni Pharmaceuticals LLC.

What class is the LIPONYX trademark registered in?

The LIPONYX trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for LIPONYX?

The USPTO serial number for LIPONYX is 98452996.

What is the registration number for LIPONYX?

LIPONYX is registered under USPTO registration number 8129341.

Sealvo

Home Search: LIPONYXLIPONYX #98452996

Back

Updated Oct 25, 2026·24 searches this week

View on USPTO TSDR Find similar marks

LIP

USPTO Trademark Record

REGISTERED

LIPONYX

SN 98452996·Reg 8129341·Filed Mar 16, 2024

Owner Nikoni Pharmaceuticals LLC

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

LIPONYX (Serial No. 98452996), Registration No. 8129341, is a registered US trademark filed on Mar 16, 2024 by Nikoni Pharmaceuticals LLC. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: February 03, 2032

Mark Intelligence

LIPONYX (Reg. #8129341) is a registered US trademark that has been protecting its owner, Nikoni Pharmaceuticals LLC, since 2024. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Mar 16, 2024

SERIAL

98452996

REG#

8129341

REGISTERED

Feb 03, 2026

Filing Information

StatusREGISTERED

Filing DateMar 16, 2024

Serial Number98452996

Registration No.8129341

Registration DateFeb 03, 2026

Status DateFeb 03, 2026

Published for OppositionJan 21, 2025

Filing Basis & Declarations

Use Application CurrentlyTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Sep 01, 2024

First use in commerce: Sep 01, 2024

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

26 events

REGISTERED-PRINCIPAL REGISTER

Feb 03, 2026

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Feb 03, 2026

NOTICE OF REGISTRATION CONFIRMATION EMAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jan 09, 2026

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Jan 09, 2026

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Dec 13, 2025

CASE ASSIGNED TO INTENT TO USE PARALEGAL

STATEMENT OF USE PROCESSING COMPLETE

Dec 13, 2025

STATEMENT OF USE PROCESSING COMPLETE

TEAS STATEMENT OF USE RECEIVED

Jun 16, 2025

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Jun 16, 2025

USE AMENDMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Mar 18, 2025

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Jan 21, 2025

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jan 21, 2025

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jan 15, 2025

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

EXAMINER'S AMENDMENT ENTERED

Dec 23, 2024

EXAMINER'S AMENDMENT ENTERED

EXAMINERS AMENDMENT E-MAILED

Dec 23, 2024

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Dec 23, 2024

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINERS AMENDMENT -WRITTEN

Dec 23, 2024

EXAMINERS AMENDMENT -WRITTEN

APPROVED FOR PUB - PRINCIPAL REGISTER

Dec 23, 2024

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Oct 06, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Oct 06, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Oct 06, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Sep 27, 2024

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Sep 27, 2024

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Sep 27, 2024

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Sep 25, 2024

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Aug 11, 2024

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Mar 16, 2024

NEW APPLICATION ENTERED

Other Marks by Nikoni Pharmaceuticals LLC

Additional USPTO filings from the same owner.

NIK

NIKONI

98752888

NIKONI PHARMACEUTICALS LLC

REGISTERED

LIPONYX

Run a conflict check

Other Marks by Nikoni Pharmaceuticals LLC

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company